** Shares in Agfa Gevaert AGFB.BR slump 9% after the
digital imaging systems producer's Q1 earnings fell short of
expectations, mainly due to the radiology division
** The division faced volume and price pressure for its
medical film products due to the new centralised procurement
practices in China, Agfa said
** ING flags concern in regards to China, as it's a critical
market for the division's profitability, it says
** It also points to "another miss" in Agfa's revenues of
EUR 396 million, standing 6.6% below the company-compiled
consensus
** Agfa's Q1 adj EBIT turned to a loss of EUR 1 million
($1.2 million), while adj EBITDA fell 36.3% to EUR 15 million
urn:newsml:reuters.com:*:nASN0016HA
** "Some declines are structural and in 2021 Agfa will
suffer from firm cost inflation," Degroof Petercam adds,
expecting 2021 to still be a tough year after a tough start
** Yet Agfa expects its price increase programmes to counter
inflationary pressure added to the COVID-19 impact
** Stock is heading for its worst day since late Aug
($1 = 0.8239 euros)
((juliette.portala@thomsonreuters.com))